AFT Pharmaceuticals Ltd. (AU:AFP) has released an update.
AFT Pharmaceuticals has struck a deal with Hainan Haiyao Co. Ltd to distribute its innovative skin infection treatment, Crystaderm cream, in China’s vast pharmaceutical market. Crystaderm offers a novel approach to treating skin infections by releasing hydrogen peroxide, providing an alternative to traditional topical antibiotics. Both companies express enthusiasm for the product’s potential in meeting the unmet clinical demand in the Chinese market.
For further insights into AU:AFP stock, check out TipRanks’ Stock Analysis page.
